In a qui tam action filed by Allstate Insurance, the court denied a clinical laboratory's motion to dismiss allegations that it submitted fraudulent claims for duplicative, excessive or medically unnecessary drug testing, finding that the insurer asserted just enough facts to meet the heightened pleading requirements of Federal Rule of Civil Procedure 9(b).